Dolby Laboratories Lowers FY2026 Adj EPS Guidance from $4.30-$4.45 to $4.25-$4.40 vs $4.30 Est; Narrows FY2026 Sales Guidance from $1.400B-$1.450B to $1.410B-$1.440B vs $1.407B Est
Dolby Laboratories (NYSE:DLB) lowers FY2026 Adj EPS guidance from $4.30-$4.45 to $4.25-$4.40 vs $4.30 analyst estimate. Narrows FY2026 sales outlook from $1.400 billion-$1.450 billion to $1.410 billion-$1.440 billion vs
Dolby Laboratories slightly lowered its profit and sales targets for next year, meaning the company expects to earn and sell a little less than it thought before. When a company adjusts its forecast down, it's worth watching to see if they're being more careful with their predictions or if something has changed in their business.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.